Luigi Pasini

Meldola, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Circulating memory B-cell receptor repertoire analysis identifies novel candidate antibodies against metastatic melanoma in immunotherapy-responsive patients.

Circulating memory B-cell receptor repertoire analysis identifies novel candidate antibodies against metastatic melanoma in immunotherapy-responsive patients.

Journal: Frontiers in immunology

Published: May 28, 2025

First real-world evidence from the Emilia-Romagna region suggests tamoxifen protects breast cancer patients from COVID-19.

First real-world evidence from the Emilia-Romagna region suggests tamoxifen protects breast cancer patients from COVID-19.

Journal: Scientific reports

Published: January 21, 2025

Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy.

Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy.

Journal: Frontiers in immunology

Published: October 23, 2024

Significant Advancements and Evolutions in Chimeric Antigen Receptor Design.

Significant Advancements and Evolutions in Chimeric Antigen Receptor Design.

Journal: International journal of molecular sciences

Published: October 17, 2024

Circulating cell-free and extracellular vesicles-derived microRNA as prognostic biomarkers in patients with early-stage NSCLC: results from RESTING study.

Circulating cell-free and extracellular vesicles-derived microRNA as prognostic biomarkers in patients with early-stage NSCLC: results from RESTING study.

Journal: Journal of experimental & clinical cancer research : CR

Published: April 12, 2024

The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung Cancer.

The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung Cancer.

Journal: Life (Basel, Switzerland)

Published: July 07, 2023

Comparative Analysis of Free-Circulating and Vesicle-Associated Plasma microRNAs of Healthy Controls and Early-Stage Lung Cancer Patients.

Comparative Analysis of Free-Circulating and Vesicle-Associated Plasma microRNAs of Healthy Controls and Early-Stage Lung Cancer Patients.

Journal: Pharmaceutics

Published: August 02, 2022

The Role of TP53 Mutations in EGFR-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy.

The Role of TP53 Mutations in EGFR-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy.

Journal: Cancers

Published: December 21, 2021

Case Report: The Added Value of Liquid Biopsy in Advanced Colorectal Cancer From Clinical Case Experiences.

Case Report: The Added Value of Liquid Biopsy in Advanced Colorectal Cancer From Clinical Case Experiences.

Journal: Frontiers in pharmacology

Published: July 22, 2021

Brigatinib in the first-line treatment of ALK+ metastatic NSCLC: safety and efficacy.

Brigatinib in the first-line treatment of ALK+ metastatic NSCLC: safety and efficacy.

Journal: Expert review of anticancer therapy

Published: April 27, 2021

Unveiling mutational dynamics in non-small cell lung cancer patients by quantitative EGFR profiling in vesicular RNA.

Unveiling mutational dynamics in non-small cell lung cancer patients by quantitative EGFR profiling in vesicular RNA.

Journal: Molecular oncology

Published: January 27, 2021

Detection of EGFR Mutations in Plasma Cell-Free Tumor DNA of TKI-Treated Advanced-NSCLC Patients by Three Methodologies: Scorpion-ARMS, PNAClamp, and Digital PCR.

Detection of EGFR Mutations in Plasma Cell-Free Tumor DNA of TKI-Treated Advanced-NSCLC Patients by Three Methodologies: Scorpion-ARMS, PNAClamp, and Digital PCR.

Journal: Diagnostics (Basel, Switzerland)

Published: November 04, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026